JP2012512255A5 - - Google Patents

Download PDF

Info

Publication number
JP2012512255A5
JP2012512255A5 JP2011542411A JP2011542411A JP2012512255A5 JP 2012512255 A5 JP2012512255 A5 JP 2012512255A5 JP 2011542411 A JP2011542411 A JP 2011542411A JP 2011542411 A JP2011542411 A JP 2011542411A JP 2012512255 A5 JP2012512255 A5 JP 2012512255A5
Authority
JP
Japan
Prior art keywords
pyridin
ylamino
phenoxy
phenyl
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2011542411A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012512255A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/068330 external-priority patent/WO2010077992A1/en
Publication of JP2012512255A publication Critical patent/JP2012512255A/ja
Publication of JP2012512255A5 publication Critical patent/JP2012512255A5/ja
Ceased legal-status Critical Current

Links

JP2011542411A 2008-12-17 2009-12-16 ホスホジエステラーゼ10阻害剤としてのアミノピリジンおよびカルボキシピリジン化合物 Ceased JP2012512255A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13843408P 2008-12-17 2008-12-17
US13844308P 2008-12-17 2008-12-17
US61/138,443 2008-12-17
US61/138,434 2008-12-17
PCT/US2009/068330 WO2010077992A1 (en) 2008-12-17 2009-12-16 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors

Publications (2)

Publication Number Publication Date
JP2012512255A JP2012512255A (ja) 2012-05-31
JP2012512255A5 true JP2012512255A5 (https=) 2013-02-14

Family

ID=41718257

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011542411A Ceased JP2012512255A (ja) 2008-12-17 2009-12-16 ホスホジエステラーゼ10阻害剤としてのアミノピリジンおよびカルボキシピリジン化合物

Country Status (10)

Country Link
US (1) US8637500B2 (https=)
EP (1) EP2376455B1 (https=)
JP (1) JP2012512255A (https=)
AR (1) AR074775A1 (https=)
AU (1) AU2009333214B2 (https=)
CA (1) CA2746307C (https=)
ES (1) ES2397934T3 (https=)
MX (1) MX2011006575A (https=)
TW (1) TW201035051A (https=)
WO (1) WO2010077992A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9051296B2 (en) 2009-11-16 2015-06-09 Raqualia Pharma Inc. Aryl carboxamide derivatives as TTX-S blockers
US8470820B2 (en) * 2010-01-22 2013-06-25 Hoffman-La Roche Inc. Nitrogen-containing heteroaryl derivatives
EP2601192B1 (en) * 2010-08-04 2017-03-01 Takeda Pharmaceutical Company Limited Fused heterocyclic compounds
CN103476757A (zh) 2011-02-18 2013-12-25 阿勒根公司 作为磷酸二酯酶10(pde10a)的抑制剂的取代的6,7-二烷氧基-3-异喹啉醇衍生物
EP2714041B1 (en) * 2011-05-24 2016-10-19 Merck Sharp & Dohme Corp. Aryloxymethyl cyclopropane derivatives as pde10 inhibitors
BR112013033375B1 (pt) * 2011-06-27 2022-05-10 Janssen Pharmaceutica N.V Derivados de 1-aril-4-metil-[1,2,4]triazolo[4,3-a]quinoxa-lina, seu uso, composição farmacêutica que os compreende, processo de preparação dos mesmos, solução estéril e composto intermediário
DK2748151T3 (en) * 2011-08-25 2016-07-04 Merck Sharp & Dohme Pyrimidine-pde10 inhibitors
US8470884B2 (en) 2011-11-09 2013-06-25 Hoffmann-La Roche Inc. Alkenyl naphthylacetic acids
WO2013148537A1 (en) * 2012-03-29 2013-10-03 Ning Xi Substituted spirobicyclic compounds and methods of use
ES2670667T3 (es) 2012-05-15 2018-05-31 Novartis Ag Derivados de benzamida para inhibir la actividad de ABL1, ABL2 y BCR-ABL1
HK1206250A1 (en) 2012-06-26 2016-01-08 Janssen Pharmaceutica Nv Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl-[1,2,4] triazolo [4,3-a] quinoxaline compounds and ped 10 inhibitors for use in the treatment of neurological or metabolic disorders
WO2014071044A1 (en) 2012-11-01 2014-05-08 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
US9200016B2 (en) 2013-12-05 2015-12-01 Allergan, Inc. Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
SG11201801856XA (en) 2015-09-18 2018-04-27 Kaken Pharmaceutical Co Ltd Biaryl derivative and medicine containing same
EA202092441A1 (ru) 2016-06-07 2021-05-21 Джакобио Фармасьютикалс Ко., Лтд. Новые гетероциклические производные, применимые в качестве ингибиторов shp2
EP3527570A4 (en) 2016-10-14 2020-04-15 Jiangsu Hengrui Medicine Co., Ltd. FIVE-LINKED HETERARYARYLE CYCLE BRIDGE DERIVATIVE, METHOD FOR PREPARING SAME, AND MEDICAL USE THEREOF
KR20240026521A (ko) 2017-03-23 2024-02-28 자코바이오 파마슈티칼스 컴퍼니 리미티드 Shp2 억제제로서 유용한 신규한 헤테로환형 유도체
JP7234201B2 (ja) * 2017-07-12 2023-03-07 ブリストル-マイヤーズ スクイブ カンパニー 心不全の治療のためのrockの5員アミノヘテロ環および5,6-または6,6員二環式アミノヘテロ環の阻害剤
CN108997230B (zh) * 2018-07-26 2020-08-04 山东大学 具有基质金属蛋白酶抑制活性的喹喔啉衍生物及其制备方法和应用
CN112839935A (zh) 2018-09-26 2021-05-25 北京加科思新药研发有限公司 可用作shp2抑制剂的新型杂环衍生物
CN116583577B (zh) 2020-12-17 2025-10-21 默克专利股份有限公司 杂芳族异硫氰酸酯
JP2025515208A (ja) * 2022-05-09 2025-05-13 ティーワイケー メディシンズ インコーポレーテッド 多環式化合物およびその使用
WO2025024681A1 (en) * 2023-07-25 2025-01-30 The Regents Of The University Of California Ire1alpha inhibitors and uses thereof
WO2025024688A1 (en) * 2023-07-25 2025-01-30 The Regents Of The University Of California Ire1alpha inhibitors and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US4198417A (en) 1979-01-10 1980-04-15 American Hoechst Corporation Phenoxyphenylpiperidines
PT72878B (en) 1980-04-24 1983-03-29 Merck & Co Inc Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
WO2001056990A2 (en) 2000-02-03 2001-08-09 Eli Lilly And Company Pyridine derivates as potentiators of glutamate receptors
WO2001087845A2 (en) * 2000-05-15 2001-11-22 Fujisawa Pharmaceutical Co., Ltd. N-containing heterocyclic compounds and their use as 5-ht antagonists
PT1635828E (pt) 2003-04-04 2008-07-01 Lundbeck & Co As H Derivados de 4-(2-feniloxifenil) piperidina ou de 1,2,3,6-tetrahidropiridina como inibidores da recaptação da serotonina
EP1651251A4 (en) 2003-07-31 2008-06-18 Bayer Pharmaceuticals Corp METHOD FOR THE TREATMENT OF DIABETES AND RELATED DISEASES USING PDE 10A INHIBITORS
JP2007504229A (ja) 2003-09-02 2007-03-01 メルク エンド カムパニー インコーポレーテッド 代謝調節型グルタミン酸受容体−5のモジュレーターとしてのビピリジルアミン類およびエーテル類
US20050250820A1 (en) * 2004-03-08 2005-11-10 Amgen Inc. Therapeutic modulation of PPARgamma activity
US20060019975A1 (en) 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
NL2000397C2 (nl) 2006-01-05 2007-10-30 Pfizer Prod Inc Bicyclische heteroarylverbindingen als PDE10 inhibitoren.
AU2007208351C1 (en) 2006-01-23 2011-07-07 Amgen Inc. Aurora kinase modulators and method of use
US7560551B2 (en) * 2006-01-23 2009-07-14 Amgen Inc. Aurora kinase modulators and method of use
JP2009535394A (ja) * 2006-05-02 2009-10-01 ファイザー・プロダクツ・インク Pde10阻害剤としての二環式ヘテロアリール化合物
US20080090834A1 (en) 2006-07-06 2008-04-17 Pfizer Inc Selective azole pde10a inhibitor compounds
WO2008057280A1 (en) 2006-10-27 2008-05-15 Amgen Inc. Multi-cyclic compounds and methods of use
ES2392156T3 (es) 2006-12-20 2012-12-05 Amgen Inc. Heterociclos sustituidos y métodos de uso
WO2009081259A1 (en) 2007-12-21 2009-07-02 Pfizer Inc. Phenoxy-pyridyl derivatives
MX2010013876A (es) 2008-06-20 2011-03-04 Metabolex Inc Agonistas de arilo grpr119 y sus usos .
TWI396689B (zh) * 2008-11-14 2013-05-21 Amgen Inc 作為磷酸二酯酶10抑制劑之吡衍生物

Similar Documents

Publication Publication Date Title
JP2012512255A5 (https=)
JP7028861B2 (ja) ピリジル置換のインドール化合物
JP6348891B2 (ja) Cxcr4受容体アンタゴニスト
JP5650735B2 (ja) タンパク質キナーゼ調節剤としてのピリジンおよびピラジン誘導体
KR101677778B1 (ko) 아미노피라진 유도체 및 의약
US20110130380A1 (en) Heteroaryl Kinase Inhibitors
US20120157433A1 (en) Heteroaryl Compounds as Kinase Inhibitors
JP2016535003A5 (https=)
JP2015500332A5 (https=)
US20120165306A1 (en) Pyrazinylpyridines useful for the treatment of proliferative diseases
JP2013537180A (ja) トリアジン−オキサジアゾール類
US20130303507A1 (en) Substituted hetero-biaryl compounds and their uses
WO2012101064A1 (en) N-acyl pyrimidine biaryl compounds as protein kinase inhibitors
JP2012512255A (ja) ホスホジエステラーゼ10阻害剤としてのアミノピリジンおよびカルボキシピリジン化合物
HRP20140778T1 (hr) Derivati tetrahidro-pirido-pirimidina
WO2012101063A1 (en) N-acyl pyridine biaryl compounds and their uses
SI2790705T1 (en) Use of activity inhibitors or PI3K function
JP2014501269A5 (https=)
JP2009544626A (ja) Itpkb阻害剤としての化合物および組成物
JPWO2012020786A1 (ja) 医薬組成物
JP5668756B2 (ja) 悪性リンパ腫治療剤
WO2012005299A1 (ja) Rosチロシンキナーゼ阻害剤
WO2007089031A1 (en) Piperidine derivatives as tachykinin receptor antagonists
AU2010209825A1 (en) Piperidine derivatives as NK3 receptor antagonists
WO2023176972A1 (ja) 高リスク骨髄線維症の治療剤